Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour

Abroad (travel likely)RecruitingPHASE2

Conditions

Leiomyosarcoma Uterus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Institut de Cancerologie de L'Ouest (Ico), Angers, France

    Contact: Principal Investigator (Patrick SOULIÉ, MD)
  • Hopital Jean Minjoz, Besançon, France

    Contact: Principal Investigator (Loic CHAIGNEAU, MD)
  • Institut Bergonie, Bordeaux, France

    Contact: Principal Investigator (Maud TOULMONDE, MD)
  • Centre Francois Baclesse, Caen, France

    Contact: Principal Investigator (Zoé NEVIERE, MD)
  • Centre Jean Perrin, Clermont-Ferrand, France

    Contact: Principal Investigator (Pascale DUBRAY-LONGERAS, MD)
  • Centre Georges Francois Leclerc, Dijon, France

    Contact: Principal Investigator (Isabelle DESMOULINS, MD)
  • Chu Limoges, Limoges, France

    Contact: Principal Investigator (Tiffany DARBAS, MD)
  • Centre Léon Berard, Lyon, France

    Contact: Principal Investigator (Isabelle RAY-COCUARD, MD PhD)
  • Institut Paoli Calmettes, Marseille, France

    Contact: Principal Investigator (François BERTUCCI, MD PhD)
  • La Timone University Hospital, Marseille, France

    Contact: Principal Investigator (Florence DUFFAUD, MD PhD)
  • Centre Antoine Lacassagne, Nice, France

    Contact: Principal Investigator (Agnès DUCOULOMBIER, MD)
  • Hopital Saint Louis, Paris, France

    Contact: Principal Investigator (Tiphaine LAMBERT, MD)
  • Hôpital Cochin, Paris, France

    Contact: Principal Investigator (Sixtine DE PERCIN, MD)
  • Groupe Hospitalier Diaconesses Croix St Simon, Paris, France

    Contact: Principal Investigator (Frédéric SELLE, MD)
  • Hopital Tenon, Paris, France

    Contact: Principal Investigator (Laurent SEKNAZI, MD)
  • Institut Curie, Paris, France

    Contact: Principal Investigator (Clément BONET, MD)
  • Chu de Poitiers, Poitiers, France

    Contact: Principal Investigator (Nicolas ISAMBERT, MD PHD)
  • Centre Eugene Marquis, Rennes, France

    Contact: Principal Investigator (Christophe PERRIN, MD)
  • Centre Henri Becquerel, Rouen, France

    Contact: Principal Investigator (Cécile GUILLEMET, MD)
  • Institut de cancerologie de l'ouest site Rene Gauducheau, Saint-Herblain, France

    Contact: Principal Investigator (Pierre KUBICEK, MD)
  • Institut de Cancerologie Strasbourg Europe (Icans), Strasbourg, France

    Contact: Study coordinator (Jean-Emmanuel KURTZ, MD)
  • Institut Claudius Regaud, Toulouse, France

    Contact: Principal Investigator (Thibaud VALENTIN, MD)
  • CHU Bretonneau, Tours, France

    Contact: Principal Investigator (Mathilde CANCEL, MD)
  • Centre Alexis Vautrin, Vandœuvre-lès-Nancy, France

    Contact: Principal Investigator (Maria RIOS, MD)
  • Gustave Roussy, Villejuif, France

    Contact: Principal Investigator (Patricia PAUTIER, MD)
Study leads
  • Florence DUFFAUD, MD

    Principal Investigator

    La TIMONE University Hospital